What's new

Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Date of authorisation: 20/03/2007, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Date of authorisation: 20/03/2007, Revision: 34, Status: Authorised

Jun 26, 2025 - 13:50
 0
Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Date of authorisation: 20/03/2007, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Date of authorisation: 20/03/2007, Revision: 34, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,tra...

Next Article

Scientific advice and protocol assistance adopted during the CHMP meeting 19-22 ...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0364/2022

Opinion/decision on a Paediatric investigation plan (PI...

May 20, 2025  0

Human medicines European public assessment report (EPAR): Yorvipath, palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 20, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Dupixent, dupilumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Dermatology, PIP number: P/0120/2022

Opinion/decision on a Paediatric investigation plan (PI...

May 20, 2025  0